Action Required: Password Reset on Next Login

As part of our recent security and system improvements, a password reset will be required the next time you log in. This applies to username/password users only; SSO users are not affected.

To reset your password, please visit the Reset Password page.

We appreciate your patience during this transition and are available to assist with any questions. For support, please call us at +1 650-552-4224 or email us at support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Immunovia AB

Headquarters: Lund, Sweden
Year Founded: 2007
Status: Public
Industry Sector: HealthTechnology
CEO: Jeff Borcherding, MBA
Number Of Employees: 9
Enterprise Value: $1,862,967
PE Ratio: -0.35
Exchange/Ticker 1: SSE:IMMNOV
Exchange/Ticker 2: N/A
Latest Market Cap: $9,232,438

BioCentury | Mar 28, 2022
Management Tracks

Asif Ali to join Protagonist as CFO

Plus new CMO at Avenge Bio, new CEO at 
BioCentury | Jan 21, 2022
Management Tracks

Blueprint promotes Philina Lee, expands Helen Ho’s role 

Plus Clyburn leaving Merck & Co. and updates from Third Rock, BioTheryX, Ambys and more
BioCentury | Dec 1, 2021
Management Tracks

Grauer becomes CMO at Federation Bio

Plus: LabGenius, 23andMe, Vifor, Immunovia, Forma and more
BioCentury | Sep 8, 2020
Management Tracks

Black Diamond names Humphrey CMO; plus Edmondson to lead chemistry at Nimbus, Recce, Amarna and more

Rachel Humphrey has joined Black Diamond Therapeutics Inc. (NASDAQ:BDTX) as CMO. Karsten Witt, who has been SVP of clinical development and acting CMO since May 2019, will become SVP of non-clinical
BioCentury | Aug 29, 2020
Management Tracks

Bi’s back; plus changes at Kymera, Immunovia, Apic, Vor, Organogenesis and more

Jingquan Bi was appointed as a deputy director of the Economic Committee of the Chinese People's Political Consultative Conference. He previously served as head of China’s State Drug
BioCentury | Jun 15, 2018
Financial News

Immunovia issues $37.3M in new shares

BioCentury | Jun 22, 2017
Targets & Mechanisms

Exosomes deliver

Codiak unveils its preclin data on exosomes for PDAC
BioCentury | Jan 4, 2016
Clinical News

IMMray PanCan-d diagnostic data

BioCentury | Dec 7, 2015
Financial News

Immunovia completes IPO

Items per page:
1 - 9 of 9